CA2164113A1 - In situ gel for therapeutic use - Google Patents
In situ gel for therapeutic useInfo
- Publication number
- CA2164113A1 CA2164113A1 CA 2164113 CA2164113A CA2164113A1 CA 2164113 A1 CA2164113 A1 CA 2164113A1 CA 2164113 CA2164113 CA 2164113 CA 2164113 A CA2164113 A CA 2164113A CA 2164113 A1 CA2164113 A1 CA 2164113A1
- Authority
- CA
- Canada
- Prior art keywords
- composition according
- composition
- solution
- drug
- mos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9301877-8 | 1993-06-02 | ||
SE9301877A SE9301877D0 (sv) | 1993-06-02 | 1993-06-02 | In situ gel for therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2164113A1 true CA2164113A1 (en) | 1994-12-08 |
Family
ID=20390132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2164113 Abandoned CA2164113A1 (en) | 1993-06-02 | 1994-06-01 | In situ gel for therapeutic use |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0706372A1 (de) |
JP (1) | JPH08510731A (de) |
AU (1) | AU6940594A (de) |
CA (1) | CA2164113A1 (de) |
SE (1) | SE9301877D0 (de) |
WO (1) | WO1994027578A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2287597A (en) * | 1996-03-13 | 1997-10-01 | Laboratoires Merck Sharp & Dohme - Chibret Snc | Ophthalmological composition of the type which undergoes liquid-gel phase tr ansition |
FR2746014B1 (fr) * | 1996-03-13 | 1999-01-08 | Composition ophtalmologique du type subissant une transition de phase liquide-gel | |
FR2754712B1 (fr) | 1996-10-17 | 1999-09-03 | Merck Sharp Dohme Chibret Lab | Compositions ophtalmiques |
EP0946197A1 (de) * | 1996-11-29 | 1999-10-06 | Monsanto Company | Gleitfähiges formbeständiges (intaktes) gel zur oralen verabreichung biologosch aktiver stoffe |
JP2004189731A (ja) * | 2002-11-26 | 2004-07-08 | Taisho Pharmaceut Co Ltd | 点鼻剤 |
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
JP5304108B2 (ja) * | 2007-08-30 | 2013-10-02 | 大正製薬株式会社 | 点眼剤 |
DE102010023949A1 (de) * | 2010-06-16 | 2011-12-22 | F. Holzer Gmbh | In-situ Lecithin-Mikroemulsionsgel-Formulierung |
US10568975B2 (en) | 2013-02-05 | 2020-02-25 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
EP3233098B1 (de) | 2014-12-15 | 2024-05-29 | The Johns Hopkins University | Cvs-transplantation zur behandlung von bakterieller vaginose |
CA2974715C (en) | 2015-01-27 | 2020-05-05 | The Johns Hopkins University | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces |
CN109260146A (zh) * | 2018-10-12 | 2019-01-25 | 广州大光制药有限公司 | 地夸磷索钠眼用即用型凝胶滴眼液及制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2588189B1 (fr) * | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
FR2657018A1 (fr) * | 1990-01-12 | 1991-07-19 | Merck Sharp & Dohme | Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation. |
CA2040460C (en) * | 1990-05-01 | 1997-06-10 | Tacey X. Viegas | Drug delivery with thermoreversible gels |
DE69212850T2 (de) * | 1991-01-15 | 1997-03-06 | Alcon Lab Inc | Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen |
-
1993
- 1993-06-02 SE SE9301877A patent/SE9301877D0/xx unknown
-
1994
- 1994-06-01 EP EP94917868A patent/EP0706372A1/de not_active Withdrawn
- 1994-06-01 AU AU69405/94A patent/AU6940594A/en not_active Abandoned
- 1994-06-01 CA CA 2164113 patent/CA2164113A1/en not_active Abandoned
- 1994-06-01 WO PCT/SE1994/000522 patent/WO1994027578A1/en not_active Application Discontinuation
- 1994-06-01 JP JP7500555A patent/JPH08510731A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1994027578A1 (en) | 1994-12-08 |
SE9301877D0 (sv) | 1993-06-02 |
AU6940594A (en) | 1994-12-20 |
EP0706372A1 (de) | 1996-04-17 |
JPH08510731A (ja) | 1996-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940000229B1 (ko) | 생리학적 액체와 접촉하여 겔화되는 약제학적 조성물의 제조방법 | |
US20240197657A1 (en) | Ketorolac tromethamine compositions for treating or preventing ocular pain | |
EP0844868B1 (de) | O-Carboxymethylchitosan enthaltende Mittel und ihre Verwendung in Ophthalmika | |
US9216167B2 (en) | Ketorolac tromethamine compositions for treating or preventing ocular pain | |
CN101312711B (zh) | 不含右泛醇、钙离子和磷酸盐的药物组合物以及钙螯合剂和眼科相容粘度调节剂的应用 | |
JP2015038099A (ja) | 防腐剤を含まない非粘性プロスタグランジン系点眼液用のポリマー送達システム | |
US20100234318A1 (en) | Ophthalmic composition containing alginic acid or salt thereof | |
MX2011013107A (es) | Composiciones farmaceuticas acuosas que contienen complejos de borato - poliol. | |
US7998942B2 (en) | Eye drop preparation comprising xanthan gum and terpenoid | |
CA2164113A1 (en) | In situ gel for therapeutic use | |
FR2660193A1 (fr) | Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules. | |
WO2001001959A1 (en) | Ophthalmic compositions in form of aqueous gels | |
US5200180A (en) | Pharmaceutical composition for the treatment of the human eye | |
AU2004305539B2 (en) | Ophthalmic compositions containing a polysaccharide/borate gelling system | |
JP5041761B2 (ja) | 眼粘膜適用製剤 | |
CA2306371C (en) | Use of flunarizine for the topical treatment of glaucoma | |
EP1749541B1 (de) | Augentropfen | |
JPS63502270A (ja) | 散瞳作用を有する眼科用医薬組成物 | |
JP2003267892A (ja) | 熱ゲル化人工涙液 | |
US8679511B2 (en) | In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |